<?xml version="1.0" encoding="UTF-8" standalone="no"?><document id="DDI-DrugBank.d59">
    <sentence id="DDI-DrugBank.d59.s0" text="The effects of ERGOMAR may be potentiated by triacetyloleandomycin which inhibits the metabolism of ergotamine.">
        <entity charOffset="15-21" id="DDI-DrugBank.d59.s0.e0" text="ERGOMAR" type="brand"/>
        <entity charOffset="45-65" id="DDI-DrugBank.d59.s0.e1" text="triacetyloleandomycin" type="drug"/>
        <entity charOffset="100-109" id="DDI-DrugBank.d59.s0.e2" text="ergotamine" type="drug"/>
        <pair ddi="true" e1="DDI-DrugBank.d59.s0.e0" e2="DDI-DrugBank.d59.s0.e1" id="DDI-DrugBank.d59.s0.p0" type="mechanism"/>
        <pair ddi="false" e1="DDI-DrugBank.d59.s0.e0" e2="DDI-DrugBank.d59.s0.e2" id="DDI-DrugBank.d59.s0.p1"/>
        <pair ddi="true" e1="DDI-DrugBank.d59.s0.e1" e2="DDI-DrugBank.d59.s0.e2" id="DDI-DrugBank.d59.s0.p2" type="mechanism"/>
    </sentence>
    <sentence id="DDI-DrugBank.d59.s1" text="The pressor effects of ERGOMAR and other vasoconstrictor drugs can combine to cause dangerous hypertension.">
        <entity charOffset="23-29" id="DDI-DrugBank.d59.s1.e0" text="ERGOMAR" type="brand"/>
        <entity charOffset="41-61" id="DDI-DrugBank.d59.s1.e1" text="vasoconstrictor drugs" type="group"/>
        <pair ddi="true" e1="DDI-DrugBank.d59.s1.e0" e2="DDI-DrugBank.d59.s1.e1" id="DDI-DrugBank.d59.s1.p0" type="effect"/>
    </sentence>
</document>